Evan Hall
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Health Informatics top 10%
Papers in
- Oncology 27
- Polyomavirus and related diseases 12
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 5
-
- Renal cell carcinoma treatment 8
- Co-authors
- Shailender Bhatia (17 shared papers)Scott S. Tykodi (8 shared papers)Kerry Kingham (3 shared papers)James M. Ford (3 shared papers)Meredith Mills (3 shared papers)Andrew J. Portuguese (2 shared papers)Christopher D. Blosser (2 shared papers)Tanya Gupta (3 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)The Oncologist (3 papers)Cancers (3 papers)Future Oncology (2 papers)Supportive Care in Cancer (2 papers)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Evan Hall
47 papers receiving 709 citations
Peers
Comparison fields: 5 of 92
- Oncology 217
- Health Informatics 11
- Transplantation 11
- Genetics 118
- Cancer Research 54
Countries citing papers authored by Evan Hall
This map shows the geographic impact of Evan Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Hall more than expected).
Fields of papers citing papers by Evan Hall
This network shows the impact of papers produced by Evan Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Hall. The network helps show where Evan Hall may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 131 | |
| 2 | 2021 | 86 | |
| 3 | 2019 | 76 | |
| 4 | 2022 | 54 | |
| 5 | 2020 | 48 | |
| 6 | 2008 | 36 | |
| 7 | 2011 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2017 | 20 | |
| 10 | 2022 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2022 | 14 | |
| 15 | 2021 | 13 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 2018 | 7 | |
| 20 | 2022 | 7 |
About Evan Hall
Evan Hall is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Molecular Biology, having authored 54 papers that have together received 721 indexed citations. Recurring topics across this work include Polyomavirus and related diseases (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Renal cell carcinoma treatment (8 papers), CAR-T cell therapy research (5 papers), Cancer Genomics and Diagnostics (4 papers), Renal and related cancers (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (217 citations), Health Informatics (11 citations), Transplantation (11 citations), Genetics (118 citations) and Cancer Research (54 citations). Evan Hall has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Shailender Bhatia, Scott S. Tykodi, Kerry Kingham, James M. Ford, Meredith Mills, Andrew J. Portuguese, Christopher D. Blosser, Tanya Gupta, Jennifer L. Caswell‐Jin and Allison W. Kurian. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Cancers, Future Oncology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.